112 related articles for article (PubMed ID: 2686319)
1. [Clinical results of using Nakom in diseases of the nervous system].
Evtushenko SK; Sadekov IA; Samsonenko RA; Mogilevskaia GS; Prokhorova LM; Ostropolets SS; Osadchiĭ VG; Va'skovskaia ME
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):35-7. PubMed ID: 2686319
[TBL] [Abstract][Full Text] [Related]
2. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
Bondarenko ES; Malyshev IuI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505
[TBL] [Abstract][Full Text] [Related]
3. [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1792-6. PubMed ID: 6229955
[TBL] [Abstract][Full Text] [Related]
4. [The differentiated treatment of dystonia musculorum deformans in children].
Mal'mberg SA
Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(5):33-6. PubMed ID: 7908772
[TBL] [Abstract][Full Text] [Related]
5. [Dopamine deficiency syndrome in children with specific reaction to the treatment with levodopa preparations].
Shoshina LM; Grinio LP; Mineeva MF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):27-32. PubMed ID: 2573987
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis and treatment of torsion dystonia].
Barkhatova VP; Markova ED
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1121-8. PubMed ID: 696099
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of the clinical course, pathogenesis and treatment of torsion dystonia in childhood].
Markova ED
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):32-5. PubMed ID: 2588895
[TBL] [Abstract][Full Text] [Related]
8. [Catecholamine excretion in torsion dystonia].
Barkatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):495-503. PubMed ID: 654723
[TBL] [Abstract][Full Text] [Related]
9. [Treatment and prognosis of the therapeutic effect of L-DOPA in dystonia musculorum deformans].
Mel'nichuk PV; Minich LN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1002-6. PubMed ID: 484133
[TBL] [Abstract][Full Text] [Related]
10. [Catecholamines metabolism in extrapyramidal disorders in children].
Mosunova TG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1466-9. PubMed ID: 930491
[TBL] [Abstract][Full Text] [Related]
11. [Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
Badalian LO; Amanova ZN; Temin PA
Lab Delo; 1984; (11):649-52. PubMed ID: 6084734
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
Perry D; Birthi P; Salles S; McDowell S
PM R; 2012 May; 4(5):383-4. PubMed ID: 22613365
[No Abstract] [Full Text] [Related]
13. [Therapy of rigidity and hypokinesis in old age using Sinemet].
Drobný M; Adamkov J; Svaleková A; Fundárek J
Cesk Neurol Neurochir; 1979 May; 42(3):195-204. PubMed ID: 455524
[No Abstract] [Full Text] [Related]
14. General discussion of drug therapy in dystonia.
Adv Neurol; 1976; 14():417-22. PubMed ID: 941782
[No Abstract] [Full Text] [Related]
15. Treatable dystonia presenting as spastic cerebral palsy.
Fink JK; Filling-Katz MR; Barton NW; Macrae PR; Hallett M; Cohen WE
Pediatrics; 1988 Jul; 82(1):137-8. PubMed ID: 3380597
[No Abstract] [Full Text] [Related]
16. [Pathogenesis of hyperkinesis in children].
Mel'nichuk PV; Khokhlov AP; Khaĭlova IM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1324-8. PubMed ID: 291244
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the test with the drug Nakom on the dynamics of excretion of catecholamines and DOPA in children with Duchenne's progressive muscular dystrophy].
Badalian LO; Temin PA; Grinio ZN; Amanova ZN; Sadovskaia IuE
Pediatriia; 1985 May; (5):54-5. PubMed ID: 3931050
[No Abstract] [Full Text] [Related]
18. Hereditary progressive dystonia with marked diurnal fluctuation.
Segawa M; Hosaka A; Miyagawa F; Nomura Y; Imai H
Adv Neurol; 1976; 14():215-33. PubMed ID: 945938
[No Abstract] [Full Text] [Related]
19. [Experience with using amedin in children with movement disorders of extrapyramidal and labyrinth origin].
Panfilova ZP; Kaganova ED; Skubak VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1495-7. PubMed ID: 716725
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of dystonia musculorum deformans].
Minich LN
Zdravookhr Kirg; 1977; (3):30-3. PubMed ID: 22183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
